REVANCE THERAPEUTICS INC (RVNC)
Institutional ownership reported to the SEC as of Q1 2025, across 26 quarters.
2
Reporting holders
$469
Reported value
0.0%
Held as options
-166
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | $425 | 86,100 | 0.00% | 19q | HELD |
| IFP Advisors, Inc | $44 | 0 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2025 | 2 | $469 | 86,100 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 168 | $270.5M | 80,817,966 | 22 | 51 | 48 | 11.6% |
| Q3 2024 | 193 | $436.7M | 82,641,417 | 65 | 37 | 51 | 2.0% |
| Q2 2024 | 166 | $216.5M | 83,507,010 | 23 | 54 | 40 | 0.9% |
| Q1 2024 | 178 | $441.6M | 88,241,911 | 37 | 55 | 49 | 1.5% |
| Q4 2023 | 178 | $701.5M | 77,537,754 | 25 | 65 | 46 | 3.0% |
| Q3 2023 | 170 | $911.5M | 77,070,009 | 21 | 74 | 50 | 3.0% |
| Q2 2023 | 186 | $2.0B | 76,467,755 | 28 | 71 | 53 | 2.8% |
| Q1 2023 | 186 | $2.5B | 74,759,952 | 43 | 55 | 59 | 2.9% |
| Q4 2022 | 158 | $1.4B | 65,107,292 | 26 | 66 | 37 | 14.9% |
| Q3 2022 | 187 | $2.2B | 67,632,363 | 45 | 66 | 39 | 15.3% |
| Q2 2022 | 165 | $801.3M | 56,033,866 | 30 | 45 | 56 | 3.4% |
| Q1 2022 | 155 | $1.1B | 54,548,570 | 23 | 42 | 59 | 3.4% |
| Q4 2021 | 154 | $891.3M | 53,133,557 | 28 | 54 | 37 | 2.7% |
| Q3 2021 | 160 | $1.5B | 54,870,642 | 15 | 50 | 42 | 1.1% |
| Q2 2021 | 162 | $1.6B | 54,100,173 | 24 | 54 | 42 | 1.1% |
| Q1 2021 | 151 | $1.6B | 54,836,055 | 17 | 54 | 51 | 1.2% |
| Q4 2020 | 152 | $1.5B | 52,894,694 | 22 | 49 | 45 | 1.5% |
| Q3 2020 | 155 | $1.3B | 49,469,832 | 22 | 64 | 38 | 1.4% |
| Q2 2020 | 144 | $1.2B | 50,607,046 | 25 | 61 | 31 | 0.5% |
| Q1 2020 | 132 | $734.6M | 49,451,885 | 18 | 49 | 37 | 0.3% |
| Q4 2019 | 136 | $841.5M | 51,621,744 | 34 | 44 | 28 | 0.4% |
| Q3 2019 | 108 | $557.3M | 42,628,782 | 13 | 47 | 20 | 0.5% |
| Q2 2019 | 112 | $570.2M | 43,681,749 | 19 | 43 | 24 | 0.8% |
| Q1 2019 | 114 | $658.9M | 41,675,978 | 21 | 50 | 16 | 0.3% |
| Q4 2018 | 104 | $742.8M | 35,616,518 | 3 | 1 | 1 | 0.2% |